COVID-19 Impacts Pharmaceutical & Biotech Industry in South America, an Industrial Info Market Brief
COVID-19 Impacts Pharmaceutical & Biotech Industry in South America, an Industrial Info Market Brief
South America's Pharmaceutical & Biotech Industry has begun to feel the impact of COVID-19, and most companies are postponing maintenance and capital projects, and only focusing on operating plants with essential staff.
For instance, Brazilian company Geolab stopped construction on a project in Anapolis, Goias, where the project's completion may take at least four more months. The same situation is happening with a grassroot project in Chorrillos, Peru, where Laboratorios Induquimica has re-scheduled authorization for expenditure within six months. In Argentina, Sinergium Biotech may not review the authorization for expenditure for its line addition project in Garin, Buenos Aires, until July.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021